Recombinant interferon gamma (Shanghai Chemo Wanbang Biopharma)

重组人干扰素γ（上海凯茂）

Report date: 2026/01/29 17:11:47

Base Information

Drug NameRecombinant interferon gamma (Shanghai Chemo Wanbang Biopharma)
Drug Alias Name伽玛gamma
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon gamma receptor stimulants
TargetsInterferon gamma receptor
Therapy Area/IndicationsGranulomatous Disease, ChronicLiver CirrhosisArthritis, Rheumatoid
Global Approved IndicationsLiver CirrhosisArthritis, Rheumatoid
Approved Indications in ChinaLiver CirrhosisArthritis, Rheumatoid
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Kaimao Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Kaimao Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGranulomatous Disease, ChronicLiver CirrhosisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeL03AB03
Related LinksN/A